Role of macrophage migration inhibitory factor in the regulation of the immune response

Advances in Immunology

Volumn 66, Issue , 1997, Pages 197-223

  Metz, Christine N ^a   Bucala, Richard ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ADENOHYPOPHYSIS; ADRENAL GLAND; BRAIN; DELAYED HYPERSENSITIVITY; DNA SEQUENCE; EYE; GENE STRUCTURE; GLOMERULONEPHRITIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INFLAMMATION; LIVER; LUNG; MACROPHAGE; MONOCYTE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SEPTIC SHOCK; T LYMPHOCYTE; TESTIS;

AMINO ACID SEQUENCE; ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; IMMUNITY; INFLAMMATION; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROTEIN CONFORMATION; RATS; RECOMBINANT PROTEINS;

EID: 0030924448     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (88)

1. Kellum, J., and Decker, J. M. (1996). The immune system: Relation to sepsis and multiple organ failure. AACN Clin. Issues 7, 339-350.
2. Parillo, J. E. (1990). Septic shock in humans: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 113, 227-242.
3. Orth, D. N., Kovacs, W. J., DeBold, C. R., Wilson, J. D., and Foster, D. W. (1992). "Williams Textbook of Endocrinology", 4th ed. Saunders, Philadelphia.
4. Goldstein, I. M., Bowen, D. L., and Fauci, A. S. (1992). Adrenal corticosteroids. In "Inflammation: Basic Principles and Clinical Correlates" (J. I. Gallin, I. M. Goldstein, and R. Snyderman, Eds.), pp. 1061-1081. Raven Press, New York.
5. Chrousos, G. P. (1995). The hypothalamie-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332, 1351-1362.
6. Munck, A., Guyre, P. M, and Holbrook, N. J. (1984). Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrinol. Rev. 5, 25-44.
7. Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., and Bucala, R. (1993). Macrophage migration inhibitory factor (MIF) is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365, 756-759.
8. Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995). MIF as a glucocorticoid-induced counter-regulator of cytokine production. Nature 377, 68-71.
9. Hawes, A. S., Rock, C. S., Keogh, C. V., Lowry, S. F., and Calvano, S. E. (1992). In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin. Infect. Immun. 60, 2641-2647.
10. Fantuzzi, G., Di Santo, E., Sacco, S., Benigni, F., and Ghezzi, P. (1995). Role of the hypothalamus-pituitary-adrenal axis in the regulation of TNF production in mice. J. Immunol. 155, 3552-3555.
11. Bertini, R., Bianchi, M., and Ghezzi, P. (1988). Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor. J. Exp. Med. 167, 1708-1712.
12. Silverstein, R., Turley, B. R., Cristofferson, C. A., Johnson, D. C, and Morrison, D. C. (1991). Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: Evidence of a role for the pituitary. J. Exp. Med. 173, 357-365.
13. George, M., and Vaughan, J. H. (1962). In vitro cell migration as a model for delayed hypersensitivity. Proc. Soc. Exp. Biol. Med. 111, 514-521.
14. Bloom, B. R., and Bennett, B. (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153, 80-82.
15. David, J. (1966). Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl. Acad. Sci. USA 56, 72-77.
16. Nathan, C. F., Remold, H. C., and David, J. R. (1973). Characterization of a lymphocyte factor which alters macrophage function. J. Exp. Med. 137, 275-288.
17. Nathan, C. F., Karnovsky, M. L., and David, J. R. (1971). Alterations of macrophage functions by mediators from lymphocytes. J. Exp. Med. 133, 1356-1376.
18. Churchill, W. H., Piessens, W. F., Sulis, C. A., and David, J. R. (1975). Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J. Immunol. 115, 781-786.
19. Weiser, W. Y., Temple, P. A., Witek-Gianotti, J. S., Remold, H. G., Clark, S. C, and David, J. R. (1989). Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 86, 7522-7526.
20. Thurman, G. B., Braude, I. A., Gray, P. W., Oldham, R. K., and Stevenson, H. C. (1985). MIF-like activity of natural and recombinant human interferon-gamma and their neutralization by monoclonal antibody. J. Immunol. 134, 305-309.
21. McInnes, A., and Rennick, D. M. (1988). Interleukin 4 induces cultured monocytes/macrophages to form giant multinucleated cells. J. Exp. Med. 167, 598-611.
22. David, J. R. (1993). Erratum: Important note on recombinant macrophage migration inhibition factor. J. Immunol. 151.
23. David, J. R. (1993). Corrections, Immunology. Proc. Natl. Acad. Sci. USA 90, 12056.
24. Bernhagen, J., Mitchell, R. A., Calandra, T., Voelter, W., Cerami, A., and Bucala, R. (1994). Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33, 14144-14155.
25. Kosak, C. A., Adamson, M. C., Buckler, C. E., Segovia, L., Paralkar, V., and Wistow, G. (1995). Genomic cloning of mouse MIF (macrophage inhibitory factor) and genetic mapping of the human and mouse expressed gene and nine mouse pseudogenes. Genomics 27, 405-411.
26. Mitchell, R., Bacher, M., Bernhagen, J., Pushkarskaya, T., Seldin, M., and Bucala, R. (1995). Cloning and characterization of the gene for mouse macrophage migration inhibitory factor (MIF). J. Immunol. 154, 3863-3870.
27. Parkalkar, V., and Wistow, G. (1994). Cloning the human gene for macrophage migration inhibitory factor (MIF). Genomics 19, 48-51.
28. Sakai, M., Nishihara, J., Hibiya, Y., Koyama, Y., and Nishi, S. (1994). Glutathione binding rat liver 13K protein is the homologue of the macrophage migration inhibitory factor. Biochem. Mol. Biol. Int. 33, 439-446.
29. Bacher, M., Meinhardt, A., Lan, H. Y., Mu, W., Metz, C. N., Chesney, J. A., Calandra, T., Gemsa, D., Donnelly, T., Atkins, R. C, and Bucala, R. (1997). Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 150, 235-246.
30. Calandra, T., Bernhagen, J., Mitchell, R. A., and Bucala, R. (1994). The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 1895-1902.
31. Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T., and Bucala, R. (1996). An essential regulatory role for MIF in T-cell activation. Proc. Natl. Acad. Sci. USA 93, 7849-7854.
32. Thorner, M. O., Vance, M. L., Horvath, E. T., and Kovacs, K. (1992). In "Williams Textbook of Endocrinology", 8th ed., Chap. 6, pp. 221-310. Saunders, Philadelphia.
33. Frantz, A. G., and Wilson, J. D. (1992). In "Williams Textbook of Endocrinology", 8th ed., Chap. 15, pp. 953-975. Saunders, Philadelphia.
34. Nishino, T., Bernhagen, J., Shiiki, H., Calandra, T., Dohi, K., and Bucala, R. (1995). Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol. Med. 1, 781-788.
35. Bernhagen, J., Bacher, M., Calandra, T., Metz, C. N., Doty, S., Donnelly, T., and Bucala, R. (1996). An essential role for macrophage migration inhibitory factor (MIF) in the tuberculin delayed-type hypersensitivity reaction. J. Exp. Med. 183, 277-282.
36. Rahman, I., Haslett, C., Rossi, A., Wallace, W., Bucala, R., Metz, C, and Donnelly, S. C. (1996). Epithelial cells are a source of macrophage migration inhibitory factor (MIF) -Potential role in acute respiratory distress syndrome (ARDS). Thorax 51, A54.
37. Donnelly, S. C., Haslett, C., Reid, P. T., Grant, I. S., Wallace, W. A. H., Metz, C. N., Bruce, L. J., and Bucala, R. (1997). Regulatory role for macrophage migration inhibitory factor (MIF) in the acute respiratory distress syndrome (ARDS). Nature Med., 3, 320-323.
38. Shimizu, T., Ohkawara, A., Nishihira, J., and Sakamoto, W. (1996). Identification of macrophage migration inhibitory factor (MIF) in human skin and its immunohistochemi-cal localization. FEBS Lett. 381, 199-202.
39. Barker, J. N., Mitra, R. S., Griffiths, C. E., Dixit, V. M., and Nickoloff, B. J. (1991). Keratinocytes as initiators of inflammation. Lancet 337, 211-214.
40. Meinhardt, A., Bacher, M., McFarlane, J. R., Metz, C. N., Seitz, J., Hedger, M. P., de Kretser, D. M., and Bucala, R. (1996). Macrophage migration inhibitory factor (MIF) production by leydig cells: Evidence for a role in the regulation of testicular function. Endocrinology 137, 5090-5095.
41. Wistow, G., Shaughnessy, M. P., Lee, D. C., Hodin, J., and Zelenka, P. S. (1993). A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc. Natl. Acad. Sci. USA 90, 1272-1275.
42. Matsuda, A., Tagawa, Y., Matsuda, H., and Nishihara, J. (1996). Identification and immunolocalization of macrophage migration inhibitory factor in human cornea. FEBS Lett. 385, 225-228.
43. Waeber, G., Calandra, T., Roduit, R., Haefliger, J. A., Thompson, N., Thorens, B., Temler, E., Meinhardt, A., Bacher, M., Metz, C. N., Nicod, P., and Bucala, R. (1997). Insulin secretion is regulated by the glucose-dependent production of islet β-cell MIF. Proc. Natl. Acad. Sci. USA, 94, 4782-4787.
44. Bacher, M., et al. (1997). MIF expression in the rat brain. Manuscript in preparation.
45. Gillis, S., Crabtree, G. R., and Smith, K. A. (1979). Glucocorticoid-induced inhibition of T cell growth factor production. J. Immunol. 123, 1624-1631.
46. Beutler, B., Krochin, N., Milsark, I. W., Luedke, C, and Cerami, A. (1986). Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232, 977-980
47. Knudsen, P. J., Dinarello, C. A., and Strom, T. B. (1987). Glucocorticoids inhibit transcriptional and post-transcriptional expression of interleukin 1 in U937 cells. J Immunol 139, 4129-4134.
48. Besedovsky, H., Del Rey, A., Sorkin, E., and Dinarello, C. A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233, 652-654.
49. Hooke, D. H., Gee, D. C., and Atkins, R. C. (1987). Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int. 31, 964-972.
50. Main, I. W., Nikolic-Paterson, D. J., and Atkins, R. C. (1992). T cells and macrophages and their role in renal injury. Sem. in Nephrol. 12, 428-440.
51. Cattell, V. (1994). Macrophages in acute glomerular inflammation. Kidney Int. 45, 945-952.
52. Van Goor, H., Ding, G., Kees-Folts, D., Grond, J., Schreiner, G. F., and Diamond, J. R. (1994). Macrophages and renal disease. Lab. Invest. 71, 456-464.
53. Lan, H. Y., Nikolic-Paterson, D. J., Mu, W., and Atkins, R. (1995). Local macrophage proliferation in the progression of glomerular tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int. 48, 753-760.
54. Lan, H. Y., Nikolic-Paterson, D. J., and Atkins, R. C. (1995). Local macrophage porlifera-tion in experimental Goodpasture's syndrome. Nephrol. 1, 151-156.
55. Lan, H. Y., Mu, W., Yang, N., Meinhardt, A., Nikolic-Paterson, D. J., Ng, Y. Y.; Bacher, M., Atkins, R. C, and Bucala, R. (1996). De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am. J. Pathol. 149, 1119-1127.
56. Lan, H. Y., Bacher, M., Yang, N., Mu, W., Nikolic-Paterson, D. J., Metz, C., Meinhardt, A., Bucala, R., and Atkins, R. C. (1997). The pathogenic role of MIF in immunologically-induced kidney disease in the rat. J. Exp. Med., 185, 1455-1465.
57. Zvaifler, N. J. (1995). Macrophages and the synovial lining. Scand. J. Rheumatol. Suppl. 101, 67-75.
58. Mikulowska, A., Metz, C., Bucala, R., and Holmdahl, R. (1997). Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II arthritis in mice. J. Immunol, 158, 5514-5517.
59. Kollef, M. H., and Schuster, D. P. (1995). The acute respiratory distress syndrome. N. Engl. J. Med. 332, 27-37.
60. Suter, P. M., Suter, S., Girardin, E., Roux-Lombard, P., Grau, G. E., and Dayer, J. M. (1992). High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin 1, interferon, and elastase in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respir. Dis. 145, 1016-1022.
61. Donnelly, S. C., Streiter, R. M., Kunkel, S. L., Walz, A., Robertson, C. R., Carter, D. C., Grant, I. S., Pollak, A. J., and Haslett, C. (1993). Interleukin-8 (IL-8) and the development of adult respiratory distress syndrome (ARDS) in at-risk patient groups. Lancet 341, 643-647.
62. Cross, C., Frei, B., and Louie, S. (1990). The adult respiratory distress syndrome (ARDS) and oxidative stress: Therapeutic implications. Adv. Exp. Med. Biol. 264, 435-438.
63. Sibbald, W. J., Anderson, R. R., Reid, B., Holliday, R. L., and Driedger, A. A. (1981). Alveolar-capillary permeability in human septic ARDS: Effect of high dose corticosteroid therapy. Chest 79, 133-142.
64. Martiney, J. A., Metz, C., Espinoza, M., Calandra, T., and Bucala, R. (1996). Role of macrophage migration inhibitory factor (MIF) in the pathophysiology of lethal mouse malaria infection. ASBMB/ASIP/AAI Joint Meeting. [Abstract.]
65. Balcerzak, S. P., Arnold, J. D., and Martin, D. C. (1972). Anatomy of red cell damage by Plasmodium falciparum in man. Blood 40, 98-104.
66. Looaresuwan, S., Merry, A. H., Phillips, R. E., Pleehachinda, R., Wattanagoon, M., Ho, M., Charoenlarp, P., Warrell, D. A., and Weatherall, D. (1987). Reduced erythrocyte survival following clearance of malarial parasitemia in Thai patients. Br. J. Hematol. 67, 473-478.
67. Abdalla, S. (1984). Hematopoiesis in human malaria. Blood Cells 16, 401-416.
68. Dormer, P., Dietrich, M., Kern, P., and Horstmann, R. D. (1983). Ineffective erythropoi-esis in acute human Plasmodium falciparum malaria. Blut. 46, 279-288.
69. Buchard, G.-D., Radloff, P., Philipps, J., Nkeyi, M., Knobloch, J., and Kremsner, P. G. (1995). Increased erythropoietin production in children with severe malarial anemia. Am. J. Trap. Med. Hyg. 53, 547-551.
70. Yap, G. S., and Stevenson, M. M. (1994). Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: Lack of a major role for interleukin-1, tumor necrosis factor alpha, and gamma interferon. Infect. Immun. 62, 357-362.
71. Sun, H., Bernhagen, J., Bucala, R., and Lolis, E. (1996). Crystal structure at 2.6A resolution of human macrophage migration inhibitory factor. Proc. Natl. Acad. Sci. USA 93, 5191-5196.
72. Kato, Y., Muto, T., Tomura, T., Tsumura, H., Watarai, H., Mikayama, T., Ishizaka, K., and Kuroki, R. (1996). The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded B-sheets. Proc. Natl. Acad. Sci. USA 93, 3007-3010.
73. Suzuki, M., Sugimoto, H., Nakagawa, A., Tanaka, I., Nishihira, J., and Sakai, M. (1996). Crystal structure of the macrophage migration inhibitory factor from rat liver. Nature Struct. Biol. 3, 259-266.
74. Bjorkman, P. J., Saper, M. A., Samraoui, B., Bennett, W. S., Strominger, J. L., and Wiley, D. C. (1987). Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329, 506-512.
75. Baldwin, E. T., Weber, I. T., St Charles, R., Xuan, J. C., Appella, E., Yamada, M., Matsushima, K., Edwards, B. F., Clore, G. M., Gronenborn, A. M, and Wlodawer, A. (1991). Crystal structure of interleukin 8: Symbiosis of NMR and crystallography. Proc. Natl. Acad. Sci. USA 88, 502-506.
76. Blocki, F. A., Schlievert, P. M., and Wackett, L. P. (1992). Rat liver protein linking chemical and immunological detoxification system. Nature 360, 269-270.
77. Pearson, W. R. (1994). MIF proteins are not glutathione transferase homologs. Prot. Sci. 3, 525-527.
78. Nishihira, J., Kuriyama, T., Sakai, M., Nishi, S., Ohki, S.-K., and Hikichi, K. (1995). The structure and physiochemical properties of rat liver macrophage migration inhibitory factor. Biochem, Biophys. Acta 1247, 159-162.
79. Subramanya, H. S., Roper, D. I., Dauter, Z., Dodson, E. J., Davies, G. J., Wilson, K. S., and Wigley, D. B. (1996). Enzymatic ketonization of 2-hydroxymuconate: Specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry 35, 792-802.
80. Rosengren, E., Bucala, R., Aman, P., Jacobsson, L., Odh, G., Metz, C. N., and Rorsman, H. (1996). The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 2, 143-149.
81. Arya, S. K., Wong-Staal, F., and Gallo, R. C. (1984). Dexamethasone-mediated inhibition of human T cell growth factor and gamma interferon messenger RNA. J. Immunol. 133, 273-377.
82. Lew, W., Oppenheim, J. J., and Matsushima, K. A. (1988). Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol. 140, 1895-1902.
83. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K., and Baldwin, A. S. (1995). Role of transcriptional activation of IκBq in mediation of immunosuppression of glucocorticoids. Science 270, 283-286.
84. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., and Karin, M. (1995). Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270, 286-290.
85. Bone, R. C., Fisher, C. J., Clemmer, T. P., Slotman, G. J., Metz, C. A., and Balk, R. A. (1987). A controlled clinical trial of high-dose methylprednisone in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 317, 653-658.
86. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987). Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N. Engl. J. Med. 317, 659-665.
87. Rossi, A. G., Haslett, C., Metz, C. N., Rahman, I., Bucala, R., and Donnelly, S. C. (1997). Eosinophils secrete macrophage migration inhibitory factor (MIF) -Potential role in asthma. ALA/ATS International Conference. [Abstract]
88. Galat, A., Riviere, S., Bouet, F., and Menez, A. (1994). A diversified family of 12 kDa proteins with a high amino acid sequence similarity to macrophage migration inhibitory factor (MIF). Eur. J. Biochem. 224, 417-421.